Mechanistic insights into the potential role of dietary polyphenols and their nanoformulation in the management of Alzheimer's disease
Language English Country France Media print-electronic
Document type Journal Article, Review
PubMed
38508080
DOI
10.1016/j.biopha.2024.116376
PII: S0753-3322(24)00260-9
Knihovny.cz E-resources
- Keywords
- Alzheimer’s disease, Dietary polyphenols, Nanoformulation, Neurodegeneration, Neuroinflammation, Neurotherapeutics,
- MeSH
- Alzheimer Disease * drug therapy diet therapy metabolism MeSH
- Amyloid beta-Peptides metabolism MeSH
- Biological Availability MeSH
- Diet MeSH
- Humans MeSH
- Nanoparticles chemistry MeSH
- Neuroprotective Agents therapeutic use pharmacology MeSH
- Polyphenols * pharmacology MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
- Names of Substances
- Amyloid beta-Peptides MeSH
- Neuroprotective Agents MeSH
- Polyphenols * MeSH
Alzheimer's disease (AD) is a very common neurodegenerative disorder associated with memory loss and a progressive decline in cognitive activity. The two major pathophysiological factors responsible for AD are amyloid plaques (comprising amyloid-beta aggregates) and neurofibrillary tangles (consisting of hyperphosphorylated tau protein). Polyphenols, a class of naturally occurring compounds, are immensely beneficial for the treatment or management of various disorders and illnesses. Naturally occurring sources of polyphenols include plants and plant-based foods, such as fruits, herbs, tea, vegetables, coffee, red wine, and dark chocolate. Polyphenols have unique properties, such as being the major source of anti-oxidants and possessing anti-aging and anti-cancerous properties. Currently, dietary polyphenols have become a potential therapeutic approach for the management of AD, depending on various research findings. Dietary polyphenols can be an effective strategy to tackle multifactorial events that occur with AD. For instance, naturally occurring polyphenols have been reported to exhibit neuroprotection by modulating the Aβ biogenesis pathway in AD. Many nanoformulations have been established to enhance the bioavailability of polyphenols, with nanonization being the most promising. This review comprehensively provides mechanistic insights into the neuroprotective potential of dietary polyphenols in treating AD. It also reviews the usability of dietary polyphenol as nanoformulation for AD treatment.
Department of Pathology Faculty of Medicine Umm Al Qura University Makkah 21955 Saudi Arabia
Department of Pharmaceutical Sciences Maharshi Dayanad University Rohtak Haryana 124001 India
Department of Zoology Kalindi College University of Delhi 110008 India
Institute of Pharmaceutical Research GLA University Mathura India
References provided by Crossref.org